Last edition
News about "ovarian cancer "
BioInvent's BI-1808 Receives FDA Fast Track Designation for Ovarian Cancer
BioInvent’s BI-1808 has received FDA Fast Track Designation for ovarian cancer, supporting accelerated development of the investigational anti-TNFR2 therapy in combination with pembrolizumab.
Ovarian Cancer | 11/08/2026 | By News Bureau
Oncoinvent has reached the halfway enrollment point in its Phase 2 trial of Radspherin, an experimental alpha-radiation therapy for ovarian cancer patients with peritoneal metastases, as recruitment accelerates across multiple international clinical sites.
Ovarian Cancer | 20/06/2026 | By News Bureau | 168
GSK Reports Positive Data for B7-H4 ADC in Gynecological Cancers
GSK reports positive BEHOLD-1 data for B7-H4 ADC mocertatug rezetecan, showing strong response rates in ovarian and endometrial cancers, with Phase 3 trials planned.
Ovarian Cancer | 14/04/2026 | By News Bureau | 190
Citius Oncology reports positive Phase I data showing encouraging safety and response rates for LYMPHIR combined with Keytruda in recurrent gynecologic cancers, supporting further Phase II evaluation.
Ovarian Cancer | 11/03/2026 | By News Bureau | 159
GSK Enters Oncology in India with Launch of Jemperli and Zejula for Gynaecological Cancers
GSK has launched its much-awaited advanced therapies Jemperli (dostarlimab) and Zejula (niraparib) in India, reinforcing its commitment to addressing the unmet need for gynaecological cancers in the country.
Ovarian Cancer | 25/08/2025 | By Dineshwori | 375
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy